Suvretta Capital Management’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-2,807,000
| Closed | -$11.8M | – | 94 |
|
|
2022
Q3 | $11.8M | Sell |
2,807,000
-444,048
| -14% | -$1.87M | 0.49% | 45 |
|
|
2022
Q2 | $9.07M | Buy |
3,251,048
+382,000
| +13% | +$1.07M | 0.34% | 58 |
|
|
2022
Q1 | $16.4M | Buy |
2,869,048
+382,708
| +15% | +$2.19M | 0.5% | 50 |
|
|
2021
Q4 | $22.7M | Buy |
2,486,340
+995,900
| +67% | +$9.09M | 0.44% | 49 |
|
|
2021
Q3 | $15.9M | Hold |
1,490,440
| – | – | 0.27% | 53 |
|
|
2021
Q2 | $23.1M | Buy |
1,490,440
+984,403
| +195% | +$15.3M | 0.35% | 57 |
|
|
2021
Q1 | $8.2M | Buy |
+506,037
| New | +$8.2M | 0.12% | 78 |
|
|
2020
Q2 | – | Sell |
-40,500
| Closed | -$475K | – | 91 |
|
|
2020
Q1 | $475K | Buy |
+40,500
| New | +$475K | 0.01% | 61 |
|